Kimberly Gentile
Direttore Tecnico/Scientifico/R&S presso BIOHAVEN LTD.
Patrimonio netto: 3 M $ in data 31/05/2024
Profilo
La signora Kimberly Gentile è vicepresidente senior delle operazioni cliniche presso la Biohaven Pharmaceutical Holding Co. Ltd. e direttore delle operazioni presso Portage Pharmaceutical Ltd. La signora Gentile è stata precedentemente impiegata come direttore associato presso Bristol Myers Squibb Co. e come Senior Manager-Clinical Trail presso SCIREX Corp. Si è laureata presso la Salem State University.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
BIOHAVEN LTD.
0.11% | 04/03/2024 | 95 969 ( 0.11% ) | 3 M $ | 31/05/2024 |
Posizioni attive di Kimberly Gentile
Società | Posizione | Inizio |
---|---|---|
BIOHAVEN LTD. | Direttore Tecnico/Scientifico/R&S | - |
Portage Pharmaceutical Ltd.
Portage Pharmaceutical Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Juvenescence Ltd., Portage Pharmaceutical Ltd. is a research and developer of biotechnology pharmaceutical drugs. The company is based in Toronto, Canada. Portage Pharmaceutical was acquired by Juvenescence Ltd. from Portage Biotech, Inc. on March 04, 2021 for $193.25 million. The CEO of the Canadian company is Frank W. Marcoux. | Direttore operativo | - |
Precedenti posizioni note di Kimberly Gentile
Società | Posizione | Fine |
---|---|---|
BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Direttore/Membro del Consiglio | 03/10/2022 |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/02/2014 |
SCIREX Corp. | Corporate Officer/Principal | 01/06/2000 |
Formazione di Kimberly Gentile
Salem State University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
BIOHAVEN LTD. | Health Technology |
Aziende private | 3 |
---|---|
Biohaven Pharmaceutical Holding Co. Ltd.
Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT. | Health Technology |
SCIREX Corp. | Commercial Services |
Portage Pharmaceutical Ltd.
Portage Pharmaceutical Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Juvenescence Ltd., Portage Pharmaceutical Ltd. is a research and developer of biotechnology pharmaceutical drugs. The company is based in Toronto, Canada. Portage Pharmaceutical was acquired by Juvenescence Ltd. from Portage Biotech, Inc. on March 04, 2021 for $193.25 million. The CEO of the Canadian company is Frank W. Marcoux. | Commercial Services |
- Borsa valori
- Insiders
- Kimberly Gentile